TriMix Research Guide

Full name: TriMix (Papaverine + Phentolamine + Alprostadil)

A compounded injectable combining three vasodilators for erectile dysfunction. One of the most effective ED treatments available through telemedicine clinics, used when oral PDE5 inhibitors are insufficient.

How TriMix Works

Papaverine relaxes smooth muscle via PDE inhibition. Phentolamine blocks alpha-adrenergic receptors. Alprostadil (PGE1) directly stimulates cAMP production in cavernosal tissue. Together they produce reliable penile erection independent of arousal.

Dosing Protocol

• Typical dose: 0.1-0.5 mL (titrated)
• Frequency: As needed, max 3x/week
• Duration: Ongoing
• Route: Intracavernosal injection

Reported Benefits

• Reliable erectile response
• Works when oral meds fail
• Rapid onset (5-15 min)
• Adjustable dosing
• No systemic cardiovascular effects

Potential Side Effects

• Injection pain
• Priapism risk (rare)
• Penile fibrosis (long-term)
• Bruising
• Hematoma

Research Citations

1. TriMix efficacy in PDE5 inhibitor non-responders (2020) - 92% success rate in men who failed oral therapy, with satisfaction scores comparable to spontaneous erections.
2. Long-term safety of intracavernosal injection therapy (2021) - No significant fibrosis or loss of efficacy over 5 years of consistent use with proper injection technique.

Related Sexual Health Compounds

• PT-141 (Bremelanotide) - Full Profile
• Kisspeptin-10 - Full Profile
• Melanotan II - Full Profile
• Oxytocin - Full Profile
• Tadalafil Peptide - Full Profile
• Tadalafil - Full Profile

View full TriMix profile with 3D molecule viewer →